A Field Efficacy Trial of a Trivalent Vaccine Containing Porcine Circovirus Type 2a and 2b, and Mycoplasma Hyopneumoniae in Three Herds

Overview

Journal Vet Med Sci

Specialty Veterinary Medicine

Date 2021 Oct 23

PMID 34687172

Citations 5

Authors

Hyungmin Um

Siyeon Yang

Taehwan Oh

Hyejean Cho

Kee Hwan Park

Jeongmin Suh

Chanhee Chae

Affiliations

Soon will be listed here.

Abstract

Background: This field trial was designed to evaluate the efficacy of a new trivalent vaccine containing porcine circovirus type 2a and 2b (PCV2a/b), and Mycoplasma hyopneumoniae at three independent locations.

Methods: Three farms were selected based on their history of PCV2 and M. hyopneumoniae co-infection. Each farm housed a total of 60, 3-day-old pigs that were randomly allocated to one of three treatment groups. Pigs were administered the trivalent vaccine intramuscularly with either a 1.0 ml dose at 3 and 24 days of age or a 2.0 ml dose at 21 days of age in accordance with the manufacturer's recommendations.

Results: Clinically, the average daily weight gain of the one-dose and two-dose vaccinated groups within all three farms was significantly higher (p < 0.05) than those of unvaccinated animals during the growing (70-112 days of age), finishing (112-175 days of age) and overall (3-175 days of age) stages of production. One-dose and two-dose vaccinated animals elicited neutralizing antibodies and interferon-γ-secreting cells (IFN-γ-SC), which reduced the amount of PCV2 in terms of blood load and reduced the severity of lymphoid lesions when compared with unvaccinated animals. Similarly, one-dose and two-dose vaccinated animals elicited IFN-γ-SC, which reduced the amount of M. hyopneumoniae in terms of laryngeal load and reduced the severity of lung lesions.

Conclusions: The intramuscular administration of either one or two doses of trivalent vaccine was not significantly different in any of the evaluated parameters. The results of field trial demonstrated that the trivalent vaccine was efficacious in the protection of swine herds where PCV2d and M. hyopneumoniae were in active circulation.

Citing Articles

A field evaluation of a new porcine circovirus type 2d and Mycoplasma hyopneumoniae bivalent vaccine in herds suffering from subclinical PCV2d infection and enzootic pneumonia.

Ham S, Suh J, Kim C, Seo B, Park G, Chae C Vet Med Sci. 2024; 10(5):e70001.

PMID: 39189840 PMC: 11348503. DOI: 10.1002/vms3.70001.

A Field Efficacy Trial of Recombinant Porcine Circovirus Type 2d Vaccine in Three Herds.

Ju L, Jayaramaiah U, Lee M, Jeong Y, You S, Lee H Vaccines (Basel). 2023; 11(9).

PMID: 37766173 PMC: 10538009. DOI: 10.3390/vaccines11091497.

Revisiting Porcine Circovirus Infection: Recent Insights and Its Significance in the Piggery Sector.

Maity H, Samanta K, Deb R, Gupta V Vaccines (Basel). 2023; 11(8).

PMID: 37631876 PMC: 10457769. DOI: 10.3390/vaccines11081308.

Detection of Porcine Circovirus 1/2/3 and Genetic Analysis of Porcine Circovirus 2 in Wild Boar from Jiangxi Province of China.

Hu X, Chen Z, Li Y, Ding Z, Zeng Q, Wan T Animals (Basel). 2022; 12(16).

PMID: 36009613 PMC: 9404430. DOI: 10.3390/ani12162021.

A field efficacy trial of a trivalent vaccine containing porcine circovirus type 2a and 2b, and Mycoplasma hyopneumoniae in three herds.

Um H, Yang S, Oh T, Cho H, Park K, Suh J Vet Med Sci. 2021; 8(2):578-590.

PMID: 34687172 PMC: 8959324. DOI: 10.1002/vms3.657.

References

Maes D, Deluyker H, Verdonck M, Castryck F, Miry C, Lein A . The effect of vaccination against Mycoplasma hypopneumoniae in pig herds with a continuous production system. Zentralbl Veterinarmed B. 1998; 45(8):495-505. DOI: 10.1111/j.1439-0450.1998.tb00820.x. View

Alarcon P, Rushton J, Wieland B . Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England - an economic disease model. Prev Vet Med. 2013; 110(2):88-102. PMC: 3652492. DOI: 10.1016/j.prevetmed.2013.02.010. View

Djordjevic S, Eamens G, Romalis L, Nicholls P, Taylor V, Chin J . Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Aust Vet J. 1997; 75(7):504-11. DOI: 10.1111/j.1751-0813.1997.tb14383.x. View

Lee C, Kang B, Lee D, Lyou S, Park B, Ann S . One-step multiplex RT-PCR for detection and subtyping of swine influenza H1, H3, N1, N2 viruses in clinical samples using a dual priming oligonucleotide (DPO) system. J Virol Methods. 2008; 151(1):30-4. DOI: 10.1016/j.jviromet.2008.04.001. View

Park C, Oh Y, Seo H, Han K, Chae C . Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model. Clin Vaccine Immunol. 2013; 20(3):369-76. PMC: 3592349. DOI: 10.1128/CVI.00497-12. View

Dubosson C, Conzelmann C, Miserez R, Boerlin P, Frey J, Zimmermann W . Development of two real-time PCR assays for the detection of Mycoplasma hyopneumoniae in clinical samples. Vet Microbiol. 2004; 102(1-2):55-65. DOI: 10.1016/j.vetmic.2004.05.007. View

Chae C . Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology. Vet J. 2004; 168(1):41-9. DOI: 10.1016/j.tvjl.2003.09.018. View

Martelli P, Ferrari L, Morganti M, De Angelis E, Bonilauri P, Guazzetti S . One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet Microbiol. 2011; 149(3-4):339-51. DOI: 10.1016/j.vetmic.2010.12.008. View

Kwon T, Lee D, Yoo S, Je S, Shin J, Lyoo Y . Genotypic diversity of porcine circovirus type 2 (PCV2) and genotype shift to PCV2d in Korean pig population. Virus Res. 2016; 228:24-29. DOI: 10.1016/j.virusres.2016.11.015. View

10.

Kim J, Chae C . Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 in porcine circovirus 2-induced granulomatous inflammation. J Comp Pathol. 2004; 131(2-3):121-6. DOI: 10.1016/j.jcpa.2004.02.001. View

11.

Kurmann J, Sydler T, Brugnera E, Buergi E, Haessig M, Suter M . Vaccination of dams increases antibody titer and improves growth parameters in finisher pigs subclinically infected with porcine circovirus type 2. Clin Vaccine Immunol. 2011; 18(10):1644-9. PMC: 3187030. DOI: 10.1128/CVI.05183-11. View

12.

Pogranichnyy R, Yoon K, Harms P, Swenson S, Zimmerman J, Sorden S . Characterization of immune response of young pigs to porcine circovirus type 2 infection. Viral Immunol. 2000; 13(2):143-53. DOI: 10.1089/vim.2000.13.143. View

13.

Park K, Oh T, Yang S, Cho H, Kang I, Chae C . Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge. Vet Microbiol. 2019; 231:87-92. DOI: 10.1016/j.vetmic.2019.03.002. View

14.

Pieters M, Daniels J, Rovira A . Comparison of sample types and diagnostic methods for in vivo detection of Mycoplasma hyopneumoniae during early stages of infection. Vet Microbiol. 2017; 203:103-109. DOI: 10.1016/j.vetmic.2017.02.014. View

15.

Segales J, Urniza A, Alegre A, Bru T, Crisci E, Nofrarias M . A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine. 2009; 27(52):7313-21. DOI: 10.1016/j.vaccine.2009.09.084. View

16.

Alarcon P, Rushton J, Nathues H, Wieland B . Economic efficiency analysis of different strategies to control post-weaning multi-systemic wasting syndrome and porcine circovirus type 2 subclinical infection in 3-weekly batch system farms. Prev Vet Med. 2013; 110(2):103-18. PMC: 3652493. DOI: 10.1016/j.prevetmed.2012.12.006. View

17.

ONeill K, Shen H, Lin K, Hemann M, Beach N, Meng X . Studies on porcine circovirus type 2 vaccination of 5-day-old piglets. Clin Vaccine Immunol. 2011; 18(11):1865-71. PMC: 3209011. DOI: 10.1128/CVI.05318-11. View

18.

Razin S, Yogev D, Naot Y . Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998; 62(4):1094-156. PMC: 98941. DOI: 10.1128/MMBR.62.4.1094-1156.1998. View

19.

Wilson S, Van Brussel L, Saunders G, Taylor L, Zimmermann L, Heinritzi K . Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight. Vaccine. 2012; 30(52):7625-9. DOI: 10.1016/j.vaccine.2012.10.028. View

20.

Chung H, Choi C, Kim J, Chae C . Detection and differentiation of North American and European genotypes of porcine reproductive and respiratory syndrome virus in formalin-fixed, paraffin-embedded tissues by multiplex reverse transcription-nested polymerase chain reaction. J Vet Diagn Invest. 2003; 14(1):56-60. DOI: 10.1177/104063870201400111. View